Valproate‐Induced Hepatic Injury: Analyses of 23 Fatal Cases

Hepatology

Volumn 2, Issue 5, 1982, Pages 591S-597S

  Zimmerman, Hyman J ^a,b   Ishak, Kamal G ^a,b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; DIAZOXIDE; ETHOSUXIMIDE; MEPHENYTOIN; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID;

ADVERSE DRUG REACTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG MECHANISM; DRUG METABOLISM; DRUG THERAPY; FATALITY; HISTOLOGY; HUMAN; INTOXICATION; LIVER; LIVER TOXICITY; THERAPY; TOXIC HEPATITIS;

ADOLESCENT; ADULT; BIOTRANSFORMATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN; INFANT; LEUKOCYTE COUNT; LIVER; LIVER DISEASES; MALE; NECROSIS; VALPROIC ACID;

EID: 0020420283     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840020513     Document Type: Article

References (29)

1. Valproic acid
2. Hepatic failure from valproic acid
3. Valproic acid and fatal hepatitis
4. Reye‐like syndrome associated with valproic acid therapy
5. Acute hepatic failure associated with the use of sodium valproate: report of two fatal cases
6. Acute liver disease associated with sodium valproate
7. Fatal hepatotoxicity in child on phenobarbitone and sodium valproate
8. Fatal Reye‐like syndromes associated with valproic acid
9. Fatal hepatic failure and sodium valproate
10. Sodium valproate and ornithine carbamyl transferase deficiency
11. Jamaican vomiting sickness: biochemical investigation of two cases
12. Jamaican vomiting sickness
13. Production of the features of Reye's syndrome in rats with 4‐pentanoic acid
14. Concentration of metabolites of valproic acid in plasma of epileptic patients
15. Metabolic pattern of valproic acid. I. Gas chromatographic determination of the valproic acid metabolite artifacts, hepatanone‐3, 4‐, and 5‐hydroxyvalproic acid lactone
16. Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy
17. Chronic valproate administration produces hepatic dysfunction and may delay brain maturation in infant mice
18. Dipropylacetate (valproate) and glycine metabolism
19. Propionic acid and dipropylacetic acid in the urine of patients treated with dipropylacetic acid
20. Valproic acid and secondary hyperammonemia
21. Effect of valproic acid on hepatic function
22. Valproate sodium in refractory seizures
23. Treatment of childhood epilepsy with valproic acid
24. A direct hepatotoxic effect of valproic acid
25. Valproic acid therapy in childhood epilepsy
26. Phenobarbital‐valproic acid interaction
27. Hepatic oncocytes: incidence, staining characteristics, and ultrastructural features
28. Oxyphilic granular hepatocytes: mitochondrion‐rich liver cells in hepatic disease